1
|
Tobola F, Lepšík M, Zia SR, Leffler H, Nilsson UJ, Blixt O, Imberty A, Wiltschi B. Engineering the ligand specificity of the human galectin-1 by incorporation of tryptophan analogs. Chembiochem 2022; 23:e202100593. [PMID: 34978765 DOI: 10.1002/cbic.202100593] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2021] [Revised: 12/23/2021] [Indexed: 11/05/2022]
Abstract
Galectin-1 is a β-galactoside-binding lectin with manifold biological functions. A single tryptophan residue (W68) in its carbohydrate binding site plays a major role in ligand binding and is highly conserved among galectins. To fine tune galectin-1 specificity, we introduced several non-canonical tryptophan analogs at this position of human galectin-1 and analyzed the resulting variants using glycan microarrays. Two variants containing 7-azatryptophan and 7-fluorotryptophan showed a reduced affinity for 3'-sulfated oligosaccharides. Their interaction with different ligands was further analyzed by fluorescence polarization competition assay. Using molecular modeling we provide structural clues that the change in affinities comes from modulated interactions and solvation patterns. Thus, we show that the introduction of subtle atomic mutations in the ligand binding site of galectin-1 is an attractive approach for fine-tuning its interactions with different ligands.
Collapse
Affiliation(s)
- Felix Tobola
- Graz University of Technology: Technische Universitat Graz, Institute of Molecular Biotechnology, Petersgasse 14, 8010, Graz, AUSTRIA
| | - Martin Lepšík
- Université Grenoble Alpes: Universite Grenoble Alpes, CNRS, CERMAV, 38000, Grenoble, FRANCE
| | | | - Hakon Leffler
- Lund University: Lunds Universitet, Laboratory Medicine Section MIG, Klinikgatan 28, 221 84, Lund, SWEDEN
| | - Ulf J Nilsson
- Lund University: Lunds Universitet, Centre for Analysis and Synthesis, Department of Chemistry, Box 124, 221 00, Lund, SWEDEN
| | - Ola Blixt
- Technical University of Denmark: Danmarks Tekniske Universitet, Biotechnology and Biomedicine, Søltofts Plads, 2800, Kgs. Lyngby, DENMARK
| | - Anne Imberty
- Université Grenoble Alpes: Universite Grenoble Alpes, CNRS, CERMAV, 38000, Grenoble, FRANCE
| | - Birgit Wiltschi
- Austrian Centre of Industrial Biotechnology, Synthetic Biology, Petersgasse 14, 8010, Graz, AUSTRIA
| |
Collapse
|
2
|
Substituting the catalytic proline of 4-oxalocrotonate tautomerase with non-canonical analogues reveals a finely tuned catalytic system. Sci Rep 2019; 9:2697. [PMID: 30804446 PMCID: PMC6389900 DOI: 10.1038/s41598-019-39484-9] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2017] [Accepted: 01/03/2019] [Indexed: 12/21/2022] Open
Abstract
The enzyme 4-oxalocrotonate tautomerase shows remarkable catalytic versatility due to the secondary amine of its N-terminal proline moiety. In this work, we incorporated a range of proline analogues into the enzyme and examined the effects on structure and activity. While the structure of the enzyme remained unperturbed, its promiscuous Michael-type activity was severely affected. This finding demonstrates how atomic changes in a biocatalytic system can abolish its activity. Our work provides a toolbox for successful generation of enzyme variants with non-canonical catalytic proline analogues.
Collapse
|